Samsung Medison acquires French AI startup Sonio
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
Samsung’s foray into M&As comes just six months after its subsidiary, Harman, acquired music platform Roon in November 2023.
Samsung Electronics said on Wednesday that Samsung Medison signed a stock purchase agreement to acquire Sonio, which specializes in ultrasound diagnostic reporting technology. Samsung Medison plans to acquire all shares of Sonio for about 126.5 billion won ($92.5 million).
Founded in 2020, Sonio aims to promote the health of pregnant women and fetuses and has developed solutions centered around ultrasound diagnostic software, enabling medical professionals to access and manage patients’ medical records with ease. Its flagship technology, “Detect,” an AI diagnostic assistance tool for obstetrics and gynecology, received approval for sale from the U.S. Food and Drug Administration (FDA) in August 2023. The enhanced version of this tool also received additional sales approval in April 2024, following which it secured large-scale supply contracts in the U.S. market.
Sonio’s AI diagnostic reporting system, which quantifies ultrasound scan results and systematically organizes them, is built on a cloud-based infrastructure, reducing initial investment costs for healthcare facilities and offering easy maintenance.
By acquiring Sonio, Samsung Medison aims to secure top-tier AI development talent in Europe and integrate Sonio’s AI diagnostic assistance capabilities and reporting technology into its own medical AI solutions. The South Korean company also anticipates that the technology will significantly reduce diagnostic time for medical professionals and improve diagnostic quality.
Heart Assist automatically measures key aspects related to the fetus’ heart, allowing easy access to automatically categorized measurement results and statistical graphs to diagnose any conditions.
Biometry Assist and View Assist, which are also based on AI, enhance measurement convenience for medical professionals and streamline the diagnostic process by automatically annotating fetal growth indicators, significantly reducing repetitive measurement tasks.
Samsung Medison’s revenue has been steadily increasing thanks to its usage of these innovative technologies. The company saw revenues of 397.3 billion won in 2021, 485.1 billion won in 2022, and 517.4 billion won in 2023, while operating profit was 86.4 billion won in 2023.
Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지
- “내 아내가 다른남성과 잠자리”…일본에 확산하는 ○○결혼의 정체 - 매일경제
- 아내가 코인으로 26억 ‘잭팟’…명퇴한 남편이 전업주부 된 사연 - 매일경제
- 감정가 2억9000만원 빌라, 2500만원에도 유찰…서울 빌라 경매 18년만에 최다 - 매일경제
- 강호동의 중대 결단…아끼는 농협·축협에 칼 들이댄다, 대체 무슨 일? - 매일경제
- “고의로 정확히 경동맥 찔렀다”…여친 살해 의대생, 미리 범죄 계획했나 - 매일경제
- “오고가는 외국인마다 ‘이것’ 들고다녀”…‘MZ패션 성지’ 떠오른 명동 가보니 - 매일경제
- [단독] “중국 가격 후려치기에 사업 접는다”…LG디스플레이, 광저우공장 매각 급물살 - 매일경
- “깜짝이야 머리가 두개네”…일본서 희귀 살모사 발견 - 매일경제
- 中에 공급업체 기술 넘긴 애플…외신 “한국도 영향권” - 매일경제
- 또 무너진 코리안 몬스터, ‘최하위’ 롯데 상대 5이닝 8피안타 5실점…한화 2연패 막지 못했다 -